Lorenz P. Studer, MD, was announced today as the winner of the 2017 Ogawa-Yamanaka Stem Cell Prize by the Gladstone Institutes. Studer is the director of the Center for Stem Cell Biology and a member of the Developmental Biology Program at the Memorial Sloan Kettering Cancer Center.
A distinguished stem cell biologist, Studer was selected for his transformative contributions to the field of cellular reprogramming and the application of human induced pluripotent stem cells (iPSCs) to human disease. His groundbreaking research has advanced the therapeutic potential of stem cell–based therapies in Parkinson’s disease and other neurological disorders.
“Dr. Studer’s visionary approach has revealed the mechanisms underlying several human neurological disorders,” said Deepak Srivastava, MD, member of the selection committee, and director of the Roddenberry Stem Cell Center at Gladstone. “His perseverance over the past few decades led to the development of a cell-based therapy for Parkinson’s disease. He is now moving his findings into clinical trials, which could help treat millions of patients suffering from this devastating disease.”
The Ogawa-Yamanaka Stem Cell Prize, sponsored by Hiro and Betty Ogawa, supports individual researchers conducting groundbreaking work in translational regenerative medicine using reprogrammed cells. It also recognizes the importance of iPSCs, discovered by Gladstone Senior Investigator and Nobel laureate Shinya Yamanaka, MD, PhD.
“I am honored to receive this prestigious prize in regenerative medicine, the topic that has been the focus of my scientific career,” said Studer. “I believe that regenerative medicine holds the key to helping people with neurological disorders, and I’m hopeful that my research will translate into real clinical applications in the near future.”
Studer was selected from a pool of outstanding nominees by an independent committee of stem cell experts. The committee was composed of George Daley, MD, PhD, dean of Harvard Medical School; Hideyuki Okano, MD, PhD, dean of the School of Medicine at Keio University; Deepak Srivastava, MD, director of the Gladstone Institute of Cardiovascular Disease and director of the Roddenberry Stem Cell Center at Gladstone; Marius Wernig, MD, associate professor at the Stanford Institute for Stem Cell Biology and Regenerative Medicine; and Shinya Yamanaka, MD, PhD, senior investigator at Gladstone and director of the Center for iPS Cell Research and Application at Kyoto University.
A ceremony will be held on November 16, 2017, at the Gladstone Institutes in San Francisco, California. Studer will give a scientific lecture and will be presented with the award, along with an unrestricted prize of $150,000 USD. The lecture and ceremony will be streamed live on Gladstone’s website, Facebook page, and YouTube channel.
Direct line: 415.734.5000
To ensure our work does the greatest good, Gladstone Institutes focuses on conditions with profound medical, economic, and social impact—unsolved diseases. Gladstone is an independent, nonprofit life science research organization that uses visionary science and technology to overcome disease. It has an academic affiliation with UC San Francisco.
Katie Pollard is recognized by the American Institute for Medical and Biological Engineering for her pioneering creation and use of statistical research toolsAwards Data Science and Biotechnology Pollard Lab